-
Signature
-
David Kwon (POA on File)
-
Stock symbol
-
ADP
-
Transactions as of
-
Aug 23, 2024
-
Transactions value $
-
-$9,321,652
-
Form type
-
4
-
Date filed
-
8/27/2024, 04:44 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ADP |
Common Stock |
Options Exercise |
$1.36M |
+7.98K |
+9.03% |
$169.84 |
96.4K |
Aug 23, 2024 |
Direct |
F1 |
transaction |
ADP |
Common Stock |
Sale |
-$2.16M |
-7.98K |
-8.28% |
$270.15 |
88.4K |
Aug 23, 2024 |
Direct |
F1 |
transaction |
ADP |
Common Stock |
Options Exercise |
$4.49M |
+26.4K |
+29.9% |
$169.84 |
115K |
Aug 26, 2024 |
Direct |
F1 |
transaction |
ADP |
Common Stock |
Sale |
-$1.07M |
-3.94K |
-3.43% |
$271.42 |
111K |
Aug 26, 2024 |
Direct |
F1 |
transaction |
ADP |
Common Stock |
Sale |
-$6.1M |
-22.5K |
-20.29% |
$270.88 |
88.4K |
Aug 26, 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
ADP |
Stock Option (Right to Buy) |
Options Exercise |
-$1.36M |
-7.98K |
-23.19% |
$169.84 |
26.4K |
Aug 23, 2024 |
Common Stock |
7.98K |
$169.84 |
Direct |
|
transaction |
ADP |
Stock Option (Right to Buy) |
Options Exercise |
-$4.49M |
-26.4K |
-100% |
$169.84 |
0 |
Aug 26, 2024 |
Common Stock |
26.4K |
$169.84 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: